Literature DB >> 10588328

Metronidazole resistance among clinical isolates belonging to the Bacteroides fragilis group: time to be concerned?

J S Brazier, S L Stubbs, B I Duerden.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10588328     DOI： 10.1093/jac/44.4.580

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  13 in total

1.  Inducible metronidazole resistance and nim genes in clinical Bacteroides fragilis group isolates.

Authors:  Sonja Löfmark; Hong Fang; Maria Hedberg; Charlotta Edlund
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

2.  Two cases of infections due to multidrug-resistant Bacteroides fragilis group strains.

Authors:  Anastasia Katsandri; Joseph Papaparaskevas; Angeliki Pantazatou; Georgios L Petrikkos; Georgios Thomopoulos; Dimitra P Houhoula; Athina Avlamis
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

3.  In vitro susceptibility to selected antibiotics in bacteria of the Bacteroides fragilis group.

Authors:  D Chmelar
Journal:  Folia Microbiol (Praha)       Date:  2009-10-14       Impact factor: 2.099

4.  In vitro activities of clindamycin, imipenem, metronidazole, and piperacillin-tazobactam against susceptible and resistant isolates of Bacteroides fragilis evaluated by kill kinetics.

Authors:  Reiner Schaumann; Matthias Funke; Eva Janssen; Arne C Rodloff
Journal:  Antimicrob Agents Chemother       Date:  2012-03-19       Impact factor: 5.191

Review 5.  Anaerobic infections: update on treatment considerations.

Authors:  Elisabeth Nagy
Journal:  Drugs       Date:  2010-05-07       Impact factor: 9.546

6.  Bacteroides fragilis group: trends in resistance.

Authors:  Manfred Fille; Monica Mango; Matthias Lechner; Reiner Schaumann
Journal:  Curr Microbiol       Date:  2006-01-31       Impact factor: 2.188

7.  National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004.

Authors:  D R Snydman; N V Jacobus; L A McDermott; R Ruthazer; Y Golan; E J C Goldstein; S M Finegold; L J Harrell; D W Hecht; S G Jenkins; C Pierson; R Venezia; V Yu; J Rihs; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  2007-02-05       Impact factor: 5.191

Review 8.  Bacteroides: the good, the bad, and the nitty-gritty.

Authors:  Hannah M Wexler
Journal:  Clin Microbiol Rev       Date:  2007-10       Impact factor: 26.132

9.  Antimicrobial susceptibility of clinical isolates of Bacteroides fragilis group organisms recovered from 2009 to 2012 in a Korean hospital.

Authors:  Jisook Yim; Yangsoon Lee; Myungsook Kim; Young Hee Seo; Wan Hee Kim; Dongeun Yong; Seok Hoon Jeong; Kyungwon Lee; Yunsop Chong
Journal:  Ann Lab Med       Date:  2014-12-08       Impact factor: 3.464

10.  A study on Nim expression in Bacteroides fragilis.

Authors:  David Leitsch; József Sóki; Daniel Kolarich; Edit Urbán; Elisabeth Nagy
Journal:  Microbiology (Reading)       Date:  2014-01-21       Impact factor: 2.777
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.